Peter Ladell

Spent a 35-year career at Hoechst Marion Roussel, where from 1997-1999 he served as COO until its merger with Rohne-Poulenc Rorer to form Aventis Pharmaceuticals. Following the merger he served as a member of the Aventis executive committee until his retirement in 2001.

  • 2005 Third Quarter

Added to: Dendrite International Inc. - Bedminster, NJ

Dendrite provides marketing and clinical compliance solutions for pharmaceutical and other life sciences companies. Revenues are $419 million.